ImageneBio Earnings Estimate

IMA Stock   6.85  0.17  2.42%   
By analyzing ImageneBio's earnings estimates, investors can diagnose different trends across ImageneBio's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for ImageneBio is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
 
Interest Hikes
ImageneBio is projected to generate -0.83 in earnings per share on the 31st of December 2026. ImageneBio earnings estimates show analyst consensus about projected ImageneBio EPS (Earning Per Share). It derives the highest and the lowest estimates based on ImageneBio's historical volatility. Many public companies, such as ImageneBio, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing ImageneBio's earnings estimates, investors can diagnose different trends across ImageneBio's analyst sentiment over time as well as compare current estimates against different timeframes. At present, ImageneBio's Gross Profit is projected to increase significantly based on the last few years of reporting. The current year's Gross Profit Margin is expected to grow to 0.84, whereas Pretax Profit Margin is forecasted to decline to (9.87). Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ImageneBio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
For information on how to trade ImageneBio Stock refer to our How to Trade ImageneBio Stock guide.

ImageneBio Earnings per Share Projection vs Actual

About ImageneBio Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of ImageneBio earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current ImageneBio estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as ImageneBio fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-298.5 M-283.5 M
Earnings Yield(0.04)(0.05)
Price Earnings Ratio(23.37)(24.54)
Price Earnings To Growth Ratio 0.80  0.76 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether ImageneBio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ImageneBio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Imagenebio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Imagenebio Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ImageneBio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
For information on how to trade ImageneBio Stock refer to our How to Trade ImageneBio Stock guide.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ImageneBio. Market participants price ImageneBio higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive ImageneBio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(4.33)
Revenue Per Share
0.011
ImageneBio's market price often diverges from its book value, the accounting figure shown on ImageneBio's balance sheet. Smart investors calculate ImageneBio's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since ImageneBio's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between ImageneBio's value and its price as these two are different measures arrived at by different means. Investors typically determine if ImageneBio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ImageneBio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.